Billiontoone, Inc. cash flow statement
In fiscal 2025, Billiontoone, Inc.'s operations generated $24.6m of cash; it spent $8.9m on capital projects, leaving free cash flow of $15.7m.
Cash flow statement
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | — | −8 | 3 | 1 | 10 | 11 | 15 | 9 |
| Depreciation and amortisation | — | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Stock-based pay | 2 | 2 | 2 | 3 | 4 | 6 | 7 | 8 |
| Capital spending | — | 2 | 2 | 3 | 2 | 2 | 4 | 4 |
| Free cash flow | — | −10 | 0 | −2 | 8 | 9 | 11 | 5 |
| Free cash flow after stock pay | — | −13 | −2 | −4 | 3 | 3 | 4 | −3 |
Compare with peers
- Twist Bioscience Corp cash flow
- Castle Biosciences Inc cash flow
- Fulgent Genetics, Inc. cash flow
- Veracyte, Inc. cash flow
- Schrodinger, Inc. cash flow
Head to head: BLLN vs TWSTBLLN vs CSTLBLLN vs FLGT
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies